These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 25703549)

  • 41. A mathematical model of the initial interaction between Mycobacterium tuberculosis and macrophages.
    Pienaar E; Lerm M
    J Theor Biol; 2014 Feb; 342():23-32. PubMed ID: 24112967
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mycobacterium tuberculosis virulence: insights and impact on vaccine development.
    Delogu G; Provvedi R; Sali M; Manganelli R
    Future Microbiol; 2015; 10(7):1177-94. PubMed ID: 26119086
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The PE and PPE proteins of Mycobacterium tuberculosis.
    Mukhopadhyay S; Balaji KN
    Tuberculosis (Edinb); 2011 Sep; 91(5):441-7. PubMed ID: 21527209
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ancestral Mycobacterium tuberculosis genotypes in India: implications for TB control programmes.
    Ahmed N; Ehtesham NZ; Hasnain SE
    Infect Genet Evol; 2009 Jan; 9(1):142-6. PubMed ID: 18992848
    [TBL] [Abstract][Full Text] [Related]  

  • 45. T cells and adaptive immunity to Mycobacterium tuberculosis in humans.
    Jasenosky LD; Scriba TJ; Hanekom WA; Goldfeld AE
    Immunol Rev; 2015 Mar; 264(1):74-87. PubMed ID: 25703553
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patterns of tuberculosis in the Americas: how can modern biomedicine inform the ancient past?
    Wilbur AK; Buikstra JE
    Mem Inst Oswaldo Cruz; 2006 Dec; 101 Suppl 2():59-66. PubMed ID: 17308811
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Shared Pathogenomic Patterns Characterize a New Phylotype, Revealing Transition toward Host-Adaptation Long before Speciation of Mycobacterium tuberculosis.
    Sapriel G; Brosch R
    Genome Biol Evol; 2019 Aug; 11(8):2420-2438. PubMed ID: 31368488
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mycobacterium tuberculosis evolutionary pathogenesis and its putative impact on drug development.
    Le Chevalier F; Cascioferro A; Majlessi L; Herrmann JL; Brosch R
    Future Microbiol; 2014; 9(8):969-85. PubMed ID: 25302954
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human and tuberculosis co-evolution: An integrative view.
    Perrin P
    Tuberculosis (Edinb); 2015 Jun; 95 Suppl 1():S112-6. PubMed ID: 25841342
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of gene targets against dormant phase Mycobacterium tuberculosis infections.
    Murphy DJ; Brown JR
    BMC Infect Dis; 2007 Jul; 7():84. PubMed ID: 17655757
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Future prospects of molecular epidemiology in tuberculosis].
    Matsumoto T; Iwamoto T
    Kekkaku; 2009 Dec; 84(12):783-4. PubMed ID: 20077862
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic engineering of Mycobacterium tuberculosis: a review.
    Lamrabet O; Drancourt M
    Tuberculosis (Edinb); 2012 Sep; 92(5):365-76. PubMed ID: 22789498
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A role for systems epidemiology in tuberculosis research.
    Comas I; Gagneux S
    Trends Microbiol; 2011 Oct; 19(10):492-500. PubMed ID: 21831640
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Sculpting of the Mycobacterium tuberculosis Genome by Host Cell-Derived Pressures.
    Russell DG; Lee W; Tan S; Sukumar N; Podinovskaia M; Fahey RJ; Vanderven BC
    Microbiol Spectr; 2014 Oct; 2(5):. PubMed ID: 25584198
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The biology of Mycobacterium cord factor and roles in pathogen-host interaction.
    Li C; Du Q; Deng W; Xie J
    Crit Rev Eukaryot Gene Expr; 2012; 22(4):289-97. PubMed ID: 23272799
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination.
    Lin MY; Geluk A; Smith SG; Stewart AL; Friggen AH; Franken KL; Verduyn MJ; van Meijgaarden KE; Voskuil MI; Dockrell HM; Huygen K; Ottenhoff TH; Klein MR
    Infect Immun; 2007 Jul; 75(7):3523-30. PubMed ID: 17502400
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthetic Long Peptide Derived from Mycobacterium tuberculosis Latency Antigen Rv1733c Protects against Tuberculosis.
    Coppola M; van den Eeden SJ; Wilson L; Franken KL; Ottenhoff TH; Geluk A
    Clin Vaccine Immunol; 2015 Sep; 22(9):1060-9. PubMed ID: 26202436
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Determinants of the Sympatric Host-Pathogen Relationship in Tuberculosis.
    David S; Mateus AR; Duarte EL; Albuquerque J; Portugal C; Sancho L; Lavinha J; Gonçalves G
    PLoS One; 2015; 10(11):e0140625. PubMed ID: 26529092
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The secret trumps, impelling the pathogenicity of tubercle bacilli.
    Cardona PJ; Ivanyi J
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():14-9. PubMed ID: 21420562
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ESX/type VII secretion systems of mycobacteria: Insights into evolution, pathogenicity and protection.
    Simeone R; Bottai D; Frigui W; Majlessi L; Brosch R
    Tuberculosis (Edinb); 2015 Jun; 95 Suppl 1():S150-4. PubMed ID: 25732627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.